Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04250727 · ClinicalTrials.gov registry record · NA
Switching to Potential Reduced Exposure Products in Adult Smokers
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04250727 is a NA study that has completed, run by Yale University. The registered enrollment target is 30 participants.
The verdict
NCT04250727, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study aims to assess the feasibility, acceptability, and the potential harm reduction of switching to potentially lower risk, oral nicotine pouches in adult smokers. Part One of this study aims to assess the interest of current smokers in switching to an e-cigarette device (i.e. JUUL) compared to alternative non-combustible tobacco products (i.e. smokeless tobacco/snus) and/or medicinal nicotine via survey. Part Two will consist of a pilot study of 30 non-treatment seeking adult smokers to investigate within-person changes in smoking behavior as a result of switching to different concentrations of oral nicotine pouch products (i.e. ZYN, 3mg and 6mg nicotine concentration). Additionally, by measuring bio-markers of tobacco exposure from baseline, this will allow the study to assess the potential for harm reduction in switching from cigarettes to oral nicotine pouches.
Interventions
- DEVICE ZYN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-08-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04250727
The ClinicalTrials.gov registry entry for NCT04250727 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ZYN is the first listed.
NCT04250727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04250727 about?
NCT04250727 is a clinical study titled "Switching to Potential Reduced Exposure Products in Adult Smokers". This study aims to assess the feasibility, acceptability, and the potential harm reduction of switching to potentially lower risk, oral nicotine pouches in adult smokers. Part One of this study aims to assess the interest of current smokers in switching to an e-cigarette device (i.e. JUUL) compared ...
What is the current status of trial NCT04250727?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-01. Estimated completion is 2022-08-17.
What interventions are being tested in trial NCT04250727?
The interventions under investigation include: ZYN (DEVICE).
Who is sponsoring clinical trial NCT04250727?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.